Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Auditor change Credit agrmnt [a] Quarterly results Appointed director CC transcript Inv. presentation
|
Option Care Health, Inc. (BIOS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/27/2023 |
8-K
| Quarterly results |
05/19/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
05/03/2023 |
8-K
| Quarterly results |
05/03/2023 |
8-K
| Quarterly results |
02/23/2023 |
8-K
| Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits Interactive Data |
01/19/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
10/27/2022 |
8-K
| Quarterly results |
09/30/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
08/18/2022 |
8-K
| Quarterly results |
07/27/2022 |
8-K
| Quarterly results |
05/20/2022 |
8-K
| Quarterly results |
04/28/2022 |
8-K
| Quarterly results |
02/23/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
11/04/2021 |
8-K
| Quarterly results |
10/29/2021 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
10/20/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
10/20/2021 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data
Docs:
|
"OPTION CARE HEALTH ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2021 AND SCHEDULES THIRD QUARTER EARNINGS CALL BANNOCKBURN, Ill., October 20, 2021 -- Option Care Health, Inc. , the nation’ s largest independent provider of home and alternate site infusion services, announced today its preliminary financial results for the third quarter ended September 30, 2021. For the third quarter, Option Care Health expects to report: · Net revenue of approximately $888 million to $893 million, representing approximately 14% growth over the prior year third quarter · Net income of approximately $33 million to $36 million · Adjusted EBITDA of approximately $76 million to $79 million, representing approximately a 28% to 34% increase over the prior ..." |
|
09/22/2021 |
8-K
| Quarterly results |
09/09/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
08/16/2021 |
8-K
| Quarterly results |
08/05/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
08/03/2021 |
8-K
| Quarterly results |
06/10/2021 |
8-K
| Quarterly results |
05/21/2021 |
8-K
| Quarterly results |
05/06/2021 |
8-K
| Quarterly results |
03/17/2021 |
8-K
| Quarterly results |
03/11/2021 |
8-K
| Quarterly results |
02/10/2021 |
8-K
| Quarterly results |
02/08/2021 |
8-K
| Quarterly results |
01/22/2021 |
8-K
| Credit agreement amendment
Docs:
|
"First Amendment to First Lien Credit Agreement, by and among Option Care Health, Inc., the guarantors party thereto, Bank of America, N.A. and the financial institutions party thereto",
"Second Amendment to ABL Credit Agreement, by and among Option Care Health, Inc., the guarantors party thereto, Bank of America, N.A. and the financial institutions party thereto",
"OPTION CARE HEALTH ANNOUNCES ISSUANCE OF $250 MILLION IN ADDITIONAL FIRST LIEN TERM LOAN AND CONCURRENT EXTINGUISHMENT OF ALL OUTSTANDING SECOND LIEN NOTES BANNOCKBURN, Ill., January 21, 2021 -- Option Care Health Inc. , the nation’ s largest independent home and alternate site infusion services provider, announced today that it has successfully issued $250 million in additional first lien term loans, the proceeds from which were used to extinguish the entire $246 million remaining outstanding balance of the Company’ s second lien notes. The terms of the additional first lien term loans, including the maturity date of August 2026, are consistent with the Company’ s existing first lien credit agreement. The Company’ s existing first lien term loans currently bear interest at Libor plus 4.25..." |
|
12/14/2020 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
11/03/2020 |
8-K
| Quarterly results |
10/06/2020 |
8-K
| Quarterly results |
08/04/2020 |
8-K
| Quarterly results |
|
|
|